From: UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
Pathological Gleason Score | ||||
---|---|---|---|---|
2 – 6 | 3 + 4 | (4 + 3) – 10 | P-value | |
UGT2B15 | 0.55* | |||
Median | 42.8 | 39.0 | 31.3 | |
Q1-Q3 | 28.8-61.9 | 21.5-65.9 | 24.5-50.5 | |
< Median | 16 (41%) | 48 (48%) | 31 (61%) | 0.15** |
≥ Median | 23 (59%) | 52 (52%) | 20 (39%) | |
UGT2B17 | 0.84* | |||
Median | 72.4 | 78.5 | 78.2 | |
Q1-Q3 | 59.8-88.1 | 58.6-94.9 | 68.2-84.6 | |
< Median | 22 (56%) | 48 (48%) | 25 (49%) | 0.66** |
≥ Median | 17 (44%) | 52 (52%) | 26 (51%) | |
UGT2B28 | 0.89* | |||
Median | 86.0 | 86.0 | 86.4 | |
Q1-Q3 | 58.4-102.9 | 63.6-109.3 | 74.1-102.2 | |
< Median | 20 (51%) | 50 (50%) | 25 (49%) | 0.98** |
≥ Median | 19 (49%) | 50 (50%) | 26 (51%) |